How to Test for Endometriosis: Your Complete Guide to Diagnosis

Why Endometriosis Takes So Long to Diagnose

The average time from first symptom to confirmed diagnosis is 7 to 10 years, a delay rooted in how often pelvic pain is normalized, misattributed, or dismissed. Endometriosis affects roughly 10% of women of reproductive age globally, yet many clinicians still frame dysmenorrhea as expected rather than pathological.

Why the Delay Happens

Several overlapping factors drive the gap between symptom onset and diagnosis.

Symptom overlap is the first problem. Pain from endometriosis can mimic irritable bowel syndrome, interstitial cystitis, pelvic inflammatory disease, adenomyosis, and even appendicitis. ACOG Practice Bulletin 114 notes that the symptom profile alone cannot reliably distinguish endometriosis from other causes of chronic pelvic pain.

Normalization is the second. Many women are told that painful periods are normal for years before anyone investigates further.

The third factor is the diagnostic gap itself: no widely available, validated blood biomarker can confirm the disease. You need either imaging evidence of a specific lesion type (an endometrioma or deep nodule) or direct surgical visualization. That surgical step is invasive, costly, and not always offered promptly.

What This Means for You Practically

If you have been told your pain is "just bad periods," you are entitled to push for systematic evaluation. Keeping a detailed symptom diary, using a validated tool like the Endometriosis Symptom Diary, gives your clinician something concrete to work with and documents the frequency, severity, and cycle-relatedness of your pain.

Step 1: Recognizing the Symptoms That Warrant Testing

Testing begins before any appointment. Knowing which symptoms are specific enough to prompt investigation matters, because not every woman presents with textbook dysmenorrhea.

Core Symptoms

The ESHRE 2022 Guideline on Endometriosis identifies these as the primary indications to investigate:

• Dysmenorrhea (period pain that limits daily activity or requires prescription analgesia)
• Deep dyspareunia (pain with penetrative sex, especially in certain positions)
• Chronic pelvic pain lasting 6 months or more
• Cyclical bowel or bladder symptoms: dyschezia, rectal bleeding, dysuria, or hematuria that worsen with menstruation
• Infertility, especially when unexplained

Symptoms Less Commonly Recognized

Less-discussed presentations include mid-cycle pain, fatigue, and shoulder tip pain (from diaphragmatic lesions). Cyclical sciatica, leg pain, or flank pain may point to extra-pelvic endometriosis, which affects an estimated 1 to 2% of cases.

Life-Stage Differences in Presentation

Adolescents and early reproductive years. Endometriosis can begin within the first few menstrual cycles. Adolescents frequently present with acyclic pain, not just menstrual pain, and may have Stage I or II disease that imaging misses entirely.

Trying to conceive. Subfertility may be the only presenting symptom. A woman trying to conceive for 12 months (or 6 months if she is 35 or older) without success should have endometriosis included in the differential even without pain.

Perimenopause. Symptoms do not always improve as estrogen fluctuates. Some women first develop significant symptoms in their 40s as estrogen levels become erratic. If you are perimenopausal and notice new or worsening pelvic pain, bowel changes, or dyspareunia, endometriosis warrants consideration alongside fibroids, adenomyosis, and ovarian pathology.

Post-menopause. Endometriosis can persist or reactivate, particularly on hormone replacement therapy (HRT). A 2023 review in Menopause journal found that post-menopausal endometriosis, though rare, carries a slightly elevated risk of malignant transformation to clear-cell or endometrioid ovarian cancer, making surveillance important.

Step 2: The Clinical Examination

A thorough physical examination is the next step and can provide meaningful diagnostic information before any imaging or blood work.

What a Pelvic Exam Can Reveal

A rectovaginal examination performed by an experienced clinician may detect uterosacral nodularity, fixed uterine retroversion, or adnexal tenderness, all of which raise the probability of endometriosis. A normal examination does not exclude it. Superficial peritoneal lesions and many ovarian endometriomas produce no palpable findings.

Performing this examination during menstruation may increase sensitivity for nodular lesions. If your examination is scheduled mid-cycle and you have significant cycle-related symptoms, ask whether rescheduling to the luteal phase or the first day or two of your period is possible.

Step 3: Imaging Tests for Endometriosis

Imaging cannot replace histology for a definitive diagnosis, but it can confirm specific lesion types with high accuracy and guide surgical planning.

Transvaginal Ultrasound (TVUS)

TVUS is the first-line imaging tool. It has high sensitivity (sensitivity 93%, specificity 97%) for ovarian endometriomas when performed by a sonographer trained in endometriosis. The characteristic appearance is a unilocular or multilocular cyst with homogeneous low-level internal echoes ("ground-glass" pattern).

TVUS performance drops significantly for superficial peritoneal lesions, where sensitivity may be as low as 10 to 20%. For deep infiltrating endometriosis (DIE) of the rectovaginal septum, TVUS sensitivity improves to roughly 79 to 95% in specialist hands using a systematic mapping protocol.

Standard gynecological ultrasound without a specific endometriosis protocol will miss most DIE. Ask explicitly whether the sonographer uses a structured endometriosis mapping approach.

MRI

MRI is used when TVUS findings are inconclusive, when DIE is suspected in locations difficult to visualize on ultrasound (bladder, ureters, diaphragm, bowel), or when pre-surgical mapping of extensive disease is needed.

A 2017 systematic review in Fertility and Sterility reported MRI sensitivity of 77% and specificity of 95% for DIE across multiple anatomical locations, with best performance for rectovaginal and bladder lesions.

MRI does not require a vaginal probe, which makes it the preferred imaging choice for women who have not yet had penetrative sex or who cannot tolerate TVUS.

Transabdominal Ultrasound

Transabdominal ultrasound alone is inadequate for detecting endometriosis in most adults. It may identify large endometriomas but lacks the resolution for DIE or small ovarian cysts. If you are offered only a transabdominal scan, ask specifically about adding the transvaginal approach.

Step 4: Blood Tests

No blood test diagnoses endometriosis. Current blood-based markers are used to support clinical suspicion or monitor response to treatment, not to confirm disease.

CA-125

CA-125 is the most studied serum marker. Its sensitivity for endometriosis overall is approximately 28%, rising to around 47 to 67% in severe (Stage III to IV) disease. Specificity is limited because CA-125 elevates in ovarian cancer, fibroids, adenomyosis, pelvic inflammatory disease, and even normal menstruation.

A normal CA-125 does not rule out endometriosis. An elevated result should prompt further investigation but is not diagnostic on its own.

Emerging Biomarkers

Research into serum, urine, and endometrial biomarkers is active. A 2022 Cochrane review evaluated 141 potential biomarkers and found none with sufficient sensitivity and specificity to replace laparoscopy in clinical practice. Panels combining multiple markers show promise but are not yet validated for routine use.

A useful clinical framework: think of biomarkers as probability adjusters, not diagnostics. A high CA-125 in a woman with typical symptoms and an endometrioma on TVUS strongly supports endometriosis and may inform surgical planning. The same result in isolation means little.

Step 5: Laparoscopy with Biopsy (The Definitive Test)

Laparoscopy remains the diagnostic gold standard. Visual inspection by an experienced surgeon identifies lesions, and tissue biopsy with histological confirmation of endometrial-like glands and stroma outside the uterus provides the definitive diagnosis.

What the Surgery Involves

Laparoscopy is performed under general anesthesia, typically as a day procedure. The surgeon inserts a camera through the navel and one to three additional small incisions. The entire pelvis, including the ovaries, fallopian tubes, uterosacral ligaments, bladder, rectovaginal space, bowel surface, and diaphragm (in thoracic cases), is systematically inspected.

ACOG recommends that surgical treatment (excision or ablation of visible lesions) be performed at the same time as diagnostic laparoscopy when feasible, reducing the need for a second procedure.

When Laparoscopy Is and Is Not the Right Next Step

The ESHRE 2022 guideline introduced a shift: empirical medical treatment (hormonal suppression) is now recommended before laparoscopy in women with typical symptoms and no indication of deep disease or ovarian cyst on imaging, provided they do not have a strong need for histological confirmation and are not primarily trying to conceive.

This approach avoids surgery for women who respond well to first-line hormonal therapy. It does mean that some women will manage presumed endometriosis without a confirmed histological diagnosis, which has implications for insurance documentation, fertility treatment protocols, and certainty of diagnosis.

Laparoscopy is the appropriate first or early step when:

• You are actively trying to conceive and want concurrent treatment
• Imaging suggests an endometrioma or DIE requiring surgical management
• Medical therapy has failed or is contraindicated
• Malignancy cannot be excluded
• You want or need a confirmed diagnosis

Risks of Laparoscopy

Serious complications occur in approximately 1 to 2 per 1,000 procedures for diagnostic laparoscopy alone, rising with complexity. Risks include bowel, bladder, or vascular injury, adhesion formation, and anesthetic complications. Choosing a surgeon with specific endometriosis expertise reduces complication rates and improves completeness of disease mapping.

Who This Diagnosis Is Right For and Who Should Wait

Not every woman with pelvic pain needs laparoscopy immediately. Clinical decision-making depends on your life stage, your fertility goals, and the severity of your symptoms.

Adolescents and Young Adults

In adolescents, the ESHRE guideline supports a trial of combined hormonal contraceptives or progestins before pursuing laparoscopy, given that surgical diagnosis is more invasive and superficial disease in young women may respond to hormonal suppression. A failure to respond to two or three months of hormonal therapy is a reasonable threshold to reconsider imaging and surgical referral.

Women Trying to Conceive

If you are trying to conceive and have suspected or confirmed endometriosis, laparoscopy with concurrent surgical treatment of endometriomas and adhesions has been shown in a landmark Marcoux et al. RCT (NEJM 1997) to increase spontaneous pregnancy rates in Stage I and II disease. For Stage III and IV disease, assisted reproduction (IVF) may be recommended alongside or instead of surgery, depending on your ovarian reserve and partner factors.

Endometriosis reduces the monthly fecundity rate to 2 to 10% compared with 15 to 20% in unaffected women, making early assessment important.

Perimenopausal Women

New or worsening pelvic pain in perimenopause deserves investigation, not assumption. Endometriosis, adenomyosis, fibroids, and ovarian pathology can coexist and present similarly. TVUS with an endometriosis protocol is the appropriate starting point. If an endometrioma is identified, surveillance or surgical management should be discussed given the slightly elevated malignancy risk in this age group.

Post-Menopausal Women on HRT

If you are post-menopausal and on HRT, particularly estrogen-only or combined continuous HRT, and you develop new pelvic pain, endometriosis reactivation must be considered. The Menopause Society advises that women with a history of endometriosis who require HRT use combined estrogen-progestogen preparations rather than estrogen alone to reduce the risk of stimulating residual disease. CA-125, TVUS, and in some cases MRI are appropriate surveillance tools.

Endometriosis and Related Conditions: What Else to Test For

Endometriosis frequently coexists with other gynecological and systemic conditions. A complete diagnostic workup should consider these.

Adenomyosis

Adenomyosis (endometrial-like tissue within the uterine muscle) coexists with endometriosis in an estimated 20 to 50% of cases. TVUS and MRI can both diagnose adenomyosis; MRI has higher accuracy for diffuse forms. If your uterus is enlarged, tender, or globular on examination, ask specifically for adenomyosis assessment.

PCOS

PCOS and endometriosis can coexist and share some symptoms, particularly irregular bleeding and pelvic discomfort. A large cohort study found that women with PCOS have a modestly elevated risk of endometriosis diagnosis, though the biological mechanism is debated. If you have PCOS and atypical pain, dyspareunia, or subfertility disproportionate to your PCOS severity, endometriosis testing is warranted.

Ovarian Cysts and Malignancy Risk

An endometrioma on ultrasound in a post-menopausal woman, or one with atypical features (thick septations, solid components, or increased vascularity on Doppler), requires oncologic assessment. CA-125, HE4, and the ROMA score are used alongside imaging to stratify malignancy risk before surgical referral.

Thyroid Function

Thyroid disease is more common in women with endometriosis than in the general population. A 2018 study found a higher prevalence of Hashimoto's thyroiditis in women with endometriosis. If you have fatigue, irregular cycles, or weight changes alongside pelvic pain, thyroid function testing (TSH, free T4, and thyroid antibodies) is a low-cost, low-risk addition to your workup.

Pregnancy, Fertility, and Contraception Considerations

Endometriosis is not a contraindication to pregnancy, but it affects fertility and changes the risk profile of pregnancy in ways you should understand.

Fertility Impact

As noted above, monthly fecundity drops significantly with endometriosis. Surgical treatment of Stage I and II disease improves spontaneous conception rates. The Marcoux et al. Trial showed a 36-week cumulative pregnancy rate of 30.7% after laparoscopic surgery versus 17.7% with diagnostic laparoscopy alone. For Stage III and IV disease, IVF is often preferred because surgery on endometriomas carries a risk of reducing ovarian reserve.

Endometriosis in Pregnancy

Endometriosis is associated with a modestly elevated risk of preterm birth, placenta previa, and cesarean delivery. Endometriomas may enlarge in the first trimester under rising estrogen and can rupture, which is a surgical emergency. Spontaneous decidualization of lesions may cause acute pelvic pain in early pregnancy.

Symptoms often improve in the second and third trimesters due to the progesterone-dominant environment of pregnancy, but this improvement is not universal.

Hormonal Suppression and Contraception

The primary medical treatments for endometriosis (combined hormonal contraceptives, progestin-only pills or IUDs, GnRH agonists, and GnRH antagonists such as elagolix) all suppress ovulation and prevent pregnancy. You cannot use these treatments while actively trying to conceive.

GnRH agonists such as leuprolide are FDA Pregnancy Category X and are contraindicated in pregnancy. Women of reproductive age taking GnRH agonists must use non-hormonal contraception if they have any possibility of ovulation (rare but not impossible on treatment). Elagolix similarly carries a contraindication in pregnancy with an FDA-mandated contraception requirement during use and for one week after stopping.

Progestin-based treatments (norethindrone acetate, dienogest, the levonorgestrel IUD) are not approved teratogens in the same category but are not intended for use in pregnancy. The levonorgestrel IUD (Mirena, Liletta) provides both suppression of endometriosis symptoms and reliable contraception simultaneously.

Lactation

Hormonal suppression is generally paused during breastfeeding because GnRH agonists are not recommended in lactating women. Progestin-only options (the mini-pill, levonorgestrel IUD, or a low-dose norethindrone) are compatible with lactation and may be used to manage pain while breastfeeding if symptoms return postpartum. Discuss timing with your prescriber, as pain management in the postpartum period is a common and underaddressed gap.

What an Endometriosis Diagnosis Actually Looks Like: A Practical Pathway

The following step-by-step pathway integrates current guidelines for a woman presenting with typical symptoms in her reproductive years. Life-stage modifications are noted in each section above.

Step 1. Document symptoms in a diary for at least two menstrual cycles. Note pain scores (0 to 10), cycle days affected, impact on daily function, and bowel or bladder symptoms.

Step 2. See a clinician trained in pelvic pain or gynecology. Request a rectovaginal examination, ideally timed near the start of menstruation.

Step 3. Arrange TVUS with an endometriosis-specific protocol. If TVUS is inconclusive and symptoms suggest DIE, proceed to MRI.

Step 4. Discuss CA-125 as a supplementary marker. Order it alongside imaging, not instead of it.

Step 5. If imaging is negative but symptoms are classic, discuss the choice between empirical hormonal treatment (combined oral contraceptive or progestin for three to six months) and laparoscopy. Your fertility timeline, symptom severity, and desire for histological confirmation all factor into this decision.

Step 6. If hormonal treatment fails or you are trying to conceive or imaging shows an endometrioma or DIE, proceed to laparoscopy with concurrent surgical treatment performed by a surgeon experienced in endometriosis excision.

Step 7. After diagnosis, discuss long-term management: suppression therapy, surgery, fertility preservation, and surveillance schedules appropriate to your life stage.